Five Prime Therapeutics (FPRX) Posts Q4 Loss of 55c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Five Prime Therapeutics (FPRX) Posts Q4 Loss of 55c/Share

Five Prime Therapeutics (FPRX) PT Raised to $31 at BMO Capital

March 18, 2015 8:26 AM EDT

BMO Capital analyst Jim Birchenough reiterated an Outperform rating and boosted his price target on Five Prime Therapeutics (NASDAQ: FPRX) to $31.00 (from $28.00) ) after the reported 4Q14 operating results yesterday. The firm sees a data-rich year end ahead.

Birchenough notes pipeline highlights include: "initiation of a phase 1a/b study of... More